# Juggling Under Controlled Hypoxia as a Multimodal Coordinative and Cognitive Training in Parkinson’s Disease—A Narrative Review

**Authors:** Dominika Grzybowska-Ganszczyk, Artur Myler, Agata Nowak-Lis, Jarosław Szczygieł, Józef Opara

PMC · DOI: 10.3390/jfmk11010075 · Journal of Functional Morphology and Kinesiology · 2026-02-12

## TL;DR

This review explores how juggling combined with controlled hypoxia might help improve cognitive and motor functions in early-stage Parkinson’s disease by promoting brain plasticity.

## Contribution

The novelty lies in proposing a novel multimodal intervention combining juggling and controlled hypoxia to enhance neuroplasticity in Parkinson’s disease.

## Key findings

- Juggling activates motor and cognitive brain regions, potentially enhancing neuroplasticity in Parkinson’s patients.
- Controlled hypoxia may amplify molecular signals like BDNF and HIF-1α, supporting brain adaptation and recovery.
- Combining juggling and hypoxia could offer a safe, innovative rehabilitation approach for early-stage Parkinson’s.

## Abstract

Parkinson’s disease (PD) is a heterogeneous clinical syndrome representing the final stage of a complex and long-lasting neurodegenerative process that involves not only dysfunction of the dopaminergic system but also impairments in other neurotransmitter systems. The diversity of the clinical presentation of PD, together with the existence of Parkinsonian syndromes and atypical Parkinsonism—such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB)—has important implications for rehabilitation outcomes and underscores the need for individualized, stage-dependent therapeutic approaches. Juggling is a complex motor activity that integrates cognitive, visuomotor, and balance processes, requiring a high level of concentration, precision, and motor adaptation. In recent years, there has been growing interest in this form of activity as a potential tool for supporting neuroplasticity, cognitive functions, and neurological rehabilitation. The aim of this review was to summarize current scientific evidence on the effects of juggling training on cognitive functions, visuomotor coordination, and balance, as well as to discuss the potential benefits of combining it with controlled hypoxia in patients with Parkinson’s disease (PD). This narrative review additionally considers how disease heterogeneity and stage of progression may influence the effectiveness of such multimodal interventions. This paper reviews the literature concerning the neurophysiological basis of learning to juggle and the mechanisms of brain plasticity, including increases in gray matter volume, improvements in white matter integrity, and reorganization of neuronal networks in motor and associative regions. Attention is drawn to the synergistic potential of combining juggling training with exposure to moderate, controlled hypoxia, which may induce an adaptive response involving the transcription factor HIF-1α, enhance the expression of brain-derived neurotrophic factor (BDNF), and promote angiogenesis and mitochondrial biogenesis. Although juggling and hypoxia are not directly related to training stimuli, both interventions activate overlapping and complementary neuroplastic pathways, providing a conceptual rationale for their parallel consideration and potential integration within future rehabilitation protocols. Juggling delivers task-specific motor–cognitive learning, whereas hypoxia may amplify molecular plasticity signaling, potentially enhancing responsiveness to motor interventions, particularly in patients at early stages of PD when compensatory mechanisms and neuroplastic capacity are relatively preserved. Findings from existing studies suggest that juggling under controlled hypoxic conditions may represent an innovative, safe, and multimodal form of training that supports both cognitive and motor components. Such effects may be particularly relevant in patients at early stages of PD, when compensatory mechanisms and neuroplastic potential are relatively preserved. Such an intervention may contribute to improvements in balance, attention, executive functions, and cognitive flexibility, which is particularly relevant in the context of rehabilitation for patients with neurodegenerative diseases. Importantly, to date, no randomized clinical trials have directly examined juggling performed under controlled hypoxic conditions in PD. Therefore, the present concept should be regarded as translational and exploratory, integrating evidence from juggling-induced neuroplasticity and hypoxia-related physiological adaptations. In this context, the proposed approach represents a proof-of-concept framework for future multimodal interventions rather than an established therapeutic strategy. Available evidence suggests that combining complex sensorimotor skill training with physiological modulation of the internal environment may constitute a novel direction in PD rehabilitation, extending beyond conventional exercise-based models. Despite promising reports, further well-designed clinical studies are needed to determine the optimal training parameters (frequency, intensity, duration, and degree of hypoxia), to evaluate the long-term sustainability of therapeutic effects, and to account for the heterogeneity of PD and related Parkinsonian disorders.

## Linked entities

- **Proteins:** HIF1A (hypoxia inducible factor 1 subunit alpha), BDNF (brain derived neurotrophic factor)
- **Diseases:** Parkinson’s disease (MONDO:0005180), multiple system atrophy (MONDO:0007803), progressive supranuclear palsy (MONDO:0019037), dementia with Lewy bodies (MONDO:0007488)

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, ARC (activity regulated cytoskeleton associated protein) [NCBI Gene 23237] {aka Arg3.1, hArc}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, MRPL49 (mitochondrial ribosomal protein L49) [NCBI Gene 740] {aka C11orf4, COXPD60, L49mt, MRP-L49, NOF, NOF1}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}
- **Diseases:** MSA (MESH:D019578), dementia (MESH:D003704), stroke (MESH:D020521), Parkinsonism (MESH:D010302), dopaminergic degeneration (MESH:D009410), respiratory (MESH:D012131), vestibular-related balance disorders (MESH:D015837), neurological diseases (MESH:D020271), Hypoxic (MESH:D002534), falls (MESH:C537863), cognitive decline (MESH:D003072), dopaminergic dysfunction (MESH:D009422), balance disorders (MESH:D009358), disability (MESH:D009069), Hypoxia (MESH:D000860), motor impairments (MESH:D000068079), Neurological disorders (MESH:D009461), muscle rigidity (MESH:D009127), PSP (MESH:D013494), bradykinesia (MESH:D018476), PD (MESH:D010300), mitochondrial disorders (MESH:D028361), apnea (MESH:D001049), injuries (MESH:D014947), neurodegeneration (MESH:D019636), Parkinsonian syndromes (MESH:D020734), inflammatory (MESH:D007249), dopamine deficiencies (MESH:C567730), cardiovascular or metabolic disorders (MESH:D024821), DLB (MESH:D020961), atrophy (MESH:D001284), Alzheimer's disease (MESH:D000544), PDD (MESH:D003966), cardiovascular diseases (MESH:D002318)
- **Chemicals:** lipid (MESH:D008055), glucose (MESH:D005947), reactive oxygen species (MESH:D017382), simvastatin (MESH:D019821), oxygen (MESH:D010100), Juggling (-), cortisol (MESH:D006854)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921876/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921876/full.md

---
Source: https://tomesphere.com/paper/PMC12921876